HomeIbex Medical Analytics

Ibex Medical Analytics

Ibex Granted FDA Breakthrough Device Designation

Ibex's Galen™ AI-powered platform is recognized by the FDA as breakthrough technology with the potential to more effectively diagnose cancer

Outstanding Performance of Ibex Medical Analytics’ AI-based Algorithm in a Study at UPMC

The study was led by Dr. Liron Pantanowitz and Dr. Rajiv Dhir, pathologists at UPMC Shadyside Hospital, who provided blinded whole slide images of prostate core needle biopsies for analysis by Ibex's Galen™ Prostate solution.

Ibex Obtains CE-IVD Mark for Galen™ Prostate Solution

With this CE-IVD Mark of Galen Prostate, Ibex is now partnering with leading institutes across Europe to implement AI and support pathologists in their diagnostic workflow.  

Ibex Medical Announced Deployment of the Ibex Second Read™ System for Breast

The system uses an artificial intelligence (AI) powered algorithm to analyse cases in parallel to pathologists and compares between the pathologists' diagnoses and the algorithm's findings, subsequently alerting in case of discrepancies with high clinical importance (e.g. a missed cancer).